Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Prevention of Esophageal Varices Worsening Post-BRTO
NCT03171805Unknown
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2017
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of propranolol in esophageal varices (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Worsening of esophageal varices rate at 3 years. Status: unknown.
02
Drugs
propranolol
03
Conditions
esophageal varices
Beyond the preview
Go deeper on NCT03171805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03171805.